This inventor holds 2 USPTO granted patents. Top assignees: Josai University Corporation, Nelson-Sumisho Co., Ltd., Other. Active years: 1993-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-2004
Title: Innovations by Toshinobu Seki
Introduction
Toshinobu Seki is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of percutaneous absorption technologies. With a total of 2 patents, his work focuses on improving drug delivery methods.
Latest Patents
One of his latest patents is titled "Moisture-sensitive preparation of percutaneous absorption type." This invention relates to a percutaneous absorption preparation that includes a supporting body, a medicine storage layer, a permeation controlling film, a layer of adhesive, and a release liner. The unique feature of this preparation is that the permeation controlling film is plasticized by moisture that volatilizes from the skin during application. Another significant patent is "Percutaneous administration of 3'-azide'-deoxythymidine." This method involves administering 3'-azide-3'-deoxythymidine (AZT) to AIDS patients by applying it to the skin along with an absorption-promoting agent. This composition is designed to enhance the absorption of AZT into the bloodstream.
Career Highlights
Throughout his career, Toshinobu Seki has worked with various companies, including Nelson-Sumisho Co., Ltd. His innovative approaches have contributed to advancements in medical treatments and drug delivery systems.
Collaborations
Toshinobu has collaborated with notable individuals in his field, including Kaname Nakahara and Yasunori Morimoto. Their joint efforts have furthered the development of effective percutaneous absorption technologies.
Conclusion
Toshinobu Seki's contributions to the field of percutaneous absorption are noteworthy. His innovative patents and collaborations highlight his commitment to improving medical treatments. His work continues to influence advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile